Get started
Author

Hanne Blakstad

Observed names: H Blakstad, Hanne Kristin Blakstad
ORCID: 0000-0003-3672-9090
Observed ORCID: 0000-0003-3672-9090
OpenAlex ID: A5031707374
Survival in a consecutive series of 467 glioblastoma patients: Association with prognostic factors and treatment at recurrence at two independent institutions
2023 · Hanne Blakstad, Jorunn Brekke, et al. · PLoS ONE · 31
PDF
Incidence and outcome of pseudoprogression after radiation therapy in glioblastoma patients: A cohort study
2023 · Hanne Blakstad, Eduardo Erasmo Mendoza Mireles, et al. · Neuro-Oncology Practice · 21
PDF
Investigating survival, quality of life and cognition in PROton versus photon therapy for IDH- mutated diffuse grade 2 and 3 GLIOmas (PRO-GLIO): a randomised controlled trial in Norway and Sweden
2023 · Liv Cathrine Heggebø, Ida Maria Henriksen Borgen, et al. · BMJ Open · 15
PDF
The impact of cancer patient pathway on timing of radiotherapy and survival: a cohort study in glioblastoma patients
2024 · Hanne Blakstad, Eduardo Erasmo Mendoza Mireles, et al. · Journal of Neuro-Oncology · 4
SMART syndrome: two cases highlighting a complex and rare complication of brain irradiation
2022 · Hanne Blakstad, Christine Wohlleben, et al. · BMJ Case Reports · 4
Astrocytoma ( CNS WHO grade 4), IDH ‐mutant with co‐occurrence of BRAF p. V600E mutation, and homozygous loss of CDKN2A
2023 · Henning Leske, Hanne Blakstad, et al. · Neuropathology · 3
Extent of resection and perioperative neurological status as prognostic markers in glioblastoma: a population-based study
2026 · Eduardo Erasmo Mendoza Mireles, Hanne Blakstad, et al. · Journal of Neuro-Oncology · 2
PDF
Case report: Pseudoprogression mimicking neoplastic recurrence three months after completion of proton beam therapy for an IDH-mutant astrocytoma CNS WHO grade 3
2025 · Liv Cathrine Heggebø, Ida Maria Henriksen Borgen, et al. · Frontiers in Oncology · 2
PDF
Clinical outcomes of genomically guided trametinib monotherapy across cancer types: results from the IMPRESS-Norway trial
2026 · Kathinka Schmidt Slørdahl, Katarina Puco, et al. · Acta Oncologica · 1
PDF
Lomustine overdose in a patient with diffuse glioma: symptoms, management and outcome
2024 · Liv Cathrine Heggebø, Hanne Blakstad, et al. · BMJ Case Reports · 1
P14.65 Survival in a consecutive series of 467 glioblastoma patients: impact of prognostic factors and recurrent treatment at two independent institutions
2021 · H Blakstad, J Brekke, et al. · Neuro-Oncology · 1
PDF
Norwegian Consensus Guidelines for Selection of Neuro-oncology Patients to Proton Therapy
2026 · Liv Cathrine Heggebø, Tor-Christian Johannessen, et al. · International Journal of Particle Therapy
PDF
Radiotherapy quality assurance in the PRO-GLIO trial: results from a dummy run comparing experts across twelve institutions in two Scandinavian countries
2026 · Liv Cathrine Heggebø, Taran Paulsen Hellebust, et al. · Clinical and Translational Radiation Oncology
PDF
Case Report: Proton beam therapy – friend or foe for patients with IDH-mutated WHO grade 2 and 3 gliomas?
2026 · Liv Cathrine Heggebø, Lars Fredrik Fjæra, et al. · Frontiers in Oncology
Norwegian consensus guidelines for selection of neuro-oncology patients to proton therapy
2026 · Liv Cathrine Heggebø, Tor-Christian Aase Johannessen, et al. · Clinical and Translational Radiation Oncology
PDF
Protons or Photons in Pituitary Neuroendocrine Tumors—That Is Not the Question
2025 · Liv Cathrine Heggebø, Frank Leonel Bello Garrote, et al. · International Journal of Particle Therapy
Surg-47. Supramaximal Resection Improves Overall Survival in Patients With Mgmt-unmethylated Glioblastoma
2024 · Eduardo Erasmo Mendoza Mireles, Hanne Blakstad, et al. · Neuro-Oncology
PDF
Optimizing Radiotherapy for Pituitary Adenomas - a Treatment Planning Study
2024 · Liv Cathrine Heggebø, Lars Fredrik Fjæra, et al. · International Journal of Particle Therapy
Radiation-Induced Optic Neuropathy Following Radiation Therapy for a Recurrent Tuberculum Sellae Meningioma: A Case Report
2024 · Liv Cathrine Heggebø, Hanne Blakstad, et al. · Applied Radiation Oncology
Ncog-11. Preoperative Nano Score as a Predictor for Survival in Glioblastoma
2023 · Eduard Mendoza Mireles, Hanne Kristin Blakstad, et al. · Neuro-Oncology
PDF
P03.14.a Dummy Run Quality Assurance Study in the Ongoing Phase 3 Randomized Pro-glio Trial
2023 · L Heggebø, T Hellebust, et al. · Neuro-Oncology
PDF
P11.75.b Pseudoprogression in a Real-world Glioblastoma Cohort: Incidence, Management, Prognostic Impact, and Associated Factors
2023 · H Blakstad, E E Mendoza Mireles, et al. · Neuro-Oncology
PDF
Works count: 22
Citation count: 85
H-index: 4
I10-index: 3
Year
Topic
Type